Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    8.00 (0.56%)
Bid:
1,442.00
Ask:
1,448.00
Spread: 6.00 (0.416%)
Market Cap: £495.75m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 20104:12 pmRNSBlocklisting Interim Review
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company
25th Jan 201012:49 pmRNSHolding(s) in Company
18th Jan 20107:00 amRNSTrading Update
23rd Dec 20097:01 amRNSGrant of Options
22nd Dec 20097:00 amRNSIntermountain Healthcare Selects Craneware
19th Nov 20093:11 pmRNSResult of AGM
19th Nov 20097:00 amRNSAGM Statement
6th Nov 20091:41 pmRNSDividend Currency Election
21st Oct 20092:46 pmRNSBlocklisting Interim Review
20th Oct 20097:00 amRNSNotice of AGM
1st Oct 200912:39 pmRNSPosting of Annual Report and Accounts
25th Sep 20097:00 amRNSContract Win
18th Sep 200911:51 amRNSDirector/PDMR Shareholding
7th Sep 20097:00 amRNSFinal Results
26th Aug 20097:00 amRNSNotice of Results
6th May 20097:00 amRNSDividend Currency Election
27th Apr 20097:00 amRNSAppointment of Non-Executive Director
16th Apr 200912:44 pmRNSBlocklisting Interim Review
14th Apr 20097:00 amRNSAgreement with US healthcare alliance
26th Mar 200911:01 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSDividend Declaration
27th Feb 20092:43 pmRNSDirector Shareholding
23rd Feb 20097:00 amRNSInterim Results
11th Feb 20096:23 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSNotice of Results
13th Jan 20097:00 amRNSTrading Update and Contract Win
19th Nov 200811:10 amRNSHolding(s) in Company
13th Nov 20085:43 pmRNSHolding(s) in Company
7th Nov 20083:04 pmRNSDividend Currency Election
4th Nov 20087:00 amRNSAGM Statement
31st Oct 20081:43 pmRNSHolding(s) in Company
31st Oct 20081:42 pmRNSHolding(s) in Company
24th Oct 200811:28 amRNSBlocklisting Interim Review
13th Oct 20087:00 amRNSNotice of AGM
16th Sep 20085:20 pmRNSHolding(s) in Company
15th Sep 20083:58 pmRNSHolding(s) in Company
9th Sep 20087:01 amRNSAppointment of a Director
9th Sep 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSTrading Statement
26th Jun 20088:32 amRNSRe Contract
25th Jun 20083:51 pmRNSHolding(s) in Company
24th Jun 20088:34 amRNSContract with CHE
5th Jun 200812:48 pmRNSBlocklisting Interim Review
4th Jun 200812:53 pmRNSHolding(s) in Company
29th May 20087:00 amRNSAppointment of Vice President
26th Feb 20087:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.